Vinflunine: drug safety evaluation of this novel synthetic vinca alkaloid

Author： Schutz Fabio AB   Bellmunt Joaquim   Rosenberg Jonathan E   Choueiri Toni K  

Publisher： Informa Healthcare

ISSN： 1474-0338

Source： Expert Opinion on Drug Safety, Vol.10, Iss.4, 2011-07, pp. : 645-653

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Vinflunine, a Second Generation Novel Vinca Alkaloid with a Distinctive Pharmacological Profile, now in Clinical Development and Prospects for Future Mitotic Blockers

By  

Current Pharmaceutical Design, Vol. 7, Iss. 13, 2001-09 ,pp. : 1199-1212

Bentham Science Publishers

Access to resources Recommend Favorite

Drug safety evaluation of defibrotide

By Richardson Paul G  

Expert Opinion on Drug Safety, Vol. 12, Iss. 1, 2013-01 ,pp. : 123-136

Informa Healthcare

Access to resources Recommend Favorite

Drug safety evaluation of amlodipine

By Derosa Giuseppe   Maffioli Pamela  

Expert Opinion on Drug Safety, Vol. 10, Iss. 5, 2011-09 ,pp. : 795-804

Informa Healthcare

Access to resources Recommend Favorite

Drug safety evaluation of exemestane

By Lintermans Anneleen   Neven Patrick   Paridaens Robert  

Expert Opinion on Drug Safety, Vol. 10, Iss. 3, 2011-05 ,pp. : 473-487

Informa Healthcare

Access to resources Recommend Favorite

A drug safety evaluation of valsartan

By Fogari Roberto   Zoppi Annalisa  

Expert Opinion on Drug Safety, Vol. 10, Iss. 2, 2011-03 ,pp. : 295-303

Informa Healthcare

Access to resources Recommend Favorite